Did Medicare induce pharmaceutical innovation?:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Cambridge, Mass.
National Bureau of Economic Research
2006
|
| Schriftenreihe: | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series
11949 |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 9, [4] S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV023591912 | ||
| 003 | DE-604 | ||
| 005 | 20090608 | ||
| 007 | t | ||
| 008 | 060328s2006 xxud||| |||| 00||| eng d | ||
| 035 | |a (OCoLC)63521156 | ||
| 035 | |a (DE-599)BVBBV023591912 | ||
| 040 | |a DE-604 |b ger | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c XD-US | ||
| 049 | |a DE-521 |a DE-19 | ||
| 050 | 0 | |a HB1.A2 | |
| 245 | 1 | 0 | |a Did Medicare induce pharmaceutical innovation? |c Daron Acemoglu ... |
| 264 | 1 | |a Cambridge, Mass. |b National Bureau of Economic Research |c 2006 | |
| 300 | |a 9, [4] S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 11949 | |
| 650 | 4 | |a Ökonometrisches Modell | |
| 650 | 4 | |a Aged |z United States | |
| 650 | 4 | |a Drug Industry |x economics |z United States | |
| 650 | 4 | |a Medicare |x Costs |x Evaluation | |
| 650 | 4 | |a Medicare |x economics | |
| 650 | 4 | |a Older people |x Medical care |x Economic aspects | |
| 650 | 4 | |a Pharmaceutical Preparations |x economics |z United States | |
| 650 | 4 | |a Prescription pricing |x Econometric models | |
| 651 | 4 | |a USA | |
| 700 | 1 | |a Acemoglu, Daron |d 1967- |e Sonstige |0 (DE-588)124929575 |4 oth | |
| 700 | 1 | |a Cutler, David M. |d 1965- |e Sonstige |0 (DE-588)124160662 |4 oth | |
| 700 | 1 | |a Finkelstein, Amy |d 1973- |e Sonstige |0 (DE-588)128781688 |4 oth | |
| 700 | 1 | |a Linn, Joshua |e Sonstige |0 (DE-588)131608681 |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |
| 830 | 0 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 11949 |w (DE-604)BV002801238 |9 11949 | |
| 856 | 4 | 1 | |u http://papers.nber.org/papers/w11949.pdf |z kostenfrei |3 Volltext |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-016907242 | ||
Datensatz im Suchindex
| _version_ | 1804138249842589696 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author_GND | (DE-588)124929575 (DE-588)124160662 (DE-588)128781688 (DE-588)131608681 |
| building | Verbundindex |
| bvnumber | BV023591912 |
| callnumber-first | H - Social Science |
| callnumber-label | HB1 |
| callnumber-raw | HB1.A2 |
| callnumber-search | HB1.A2 |
| callnumber-sort | HB 11 A2 |
| callnumber-subject | HB - Economic Theory and Demography |
| ctrlnum | (OCoLC)63521156 (DE-599)BVBBV023591912 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01783nam a2200457zcb4500</leader><controlfield tag="001">BV023591912</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20090608 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">060328s2006 xxud||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)63521156</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV023591912</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-521</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HB1.A2</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Did Medicare induce pharmaceutical innovation?</subfield><subfield code="c">Daron Acemoglu ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, Mass.</subfield><subfield code="b">National Bureau of Economic Research</subfield><subfield code="c">2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9, [4] S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">11949</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ökonometrisches Modell</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Aged</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="x">economics</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicare</subfield><subfield code="x">Costs</subfield><subfield code="x">Evaluation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicare</subfield><subfield code="x">economics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Older people</subfield><subfield code="x">Medical care</subfield><subfield code="x">Economic aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical Preparations</subfield><subfield code="x">economics</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prescription pricing</subfield><subfield code="x">Econometric models</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Acemoglu, Daron</subfield><subfield code="d">1967-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)124929575</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cutler, David M.</subfield><subfield code="d">1965-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)124160662</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Finkelstein, Amy</subfield><subfield code="d">1973-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)128781688</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Linn, Joshua</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)131608681</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">11949</subfield><subfield code="w">(DE-604)BV002801238</subfield><subfield code="9">11949</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://papers.nber.org/papers/w11949.pdf</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016907242</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV023591912 |
| illustrated | Illustrated |
| index_date | 2024-07-02T22:41:29Z |
| indexdate | 2024-07-09T21:25:12Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016907242 |
| oclc_num | 63521156 |
| open_access_boolean | 1 |
| owner | DE-521 DE-19 DE-BY-UBM |
| owner_facet | DE-521 DE-19 DE-BY-UBM |
| physical | 9, [4] S. graph. Darst. |
| publishDate | 2006 |
| publishDateSearch | 2006 |
| publishDateSort | 2006 |
| publisher | National Bureau of Economic Research |
| record_format | marc |
| series | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| series2 | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| spelling | Did Medicare induce pharmaceutical innovation? Daron Acemoglu ... Cambridge, Mass. National Bureau of Economic Research 2006 9, [4] S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 11949 Ökonometrisches Modell Aged United States Drug Industry economics United States Medicare Costs Evaluation Medicare economics Older people Medical care Economic aspects Pharmaceutical Preparations economics United States Prescription pricing Econometric models USA Acemoglu, Daron 1967- Sonstige (DE-588)124929575 oth Cutler, David M. 1965- Sonstige (DE-588)124160662 oth Finkelstein, Amy 1973- Sonstige (DE-588)128781688 oth Linn, Joshua Sonstige (DE-588)131608681 oth Erscheint auch als Online-Ausgabe National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 11949 (DE-604)BV002801238 11949 http://papers.nber.org/papers/w11949.pdf kostenfrei Volltext |
| spellingShingle | Did Medicare induce pharmaceutical innovation? National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series Ökonometrisches Modell Aged United States Drug Industry economics United States Medicare Costs Evaluation Medicare economics Older people Medical care Economic aspects Pharmaceutical Preparations economics United States Prescription pricing Econometric models |
| title | Did Medicare induce pharmaceutical innovation? |
| title_auth | Did Medicare induce pharmaceutical innovation? |
| title_exact_search | Did Medicare induce pharmaceutical innovation? |
| title_exact_search_txtP | Did Medicare induce pharmaceutical innovation? |
| title_full | Did Medicare induce pharmaceutical innovation? Daron Acemoglu ... |
| title_fullStr | Did Medicare induce pharmaceutical innovation? Daron Acemoglu ... |
| title_full_unstemmed | Did Medicare induce pharmaceutical innovation? Daron Acemoglu ... |
| title_short | Did Medicare induce pharmaceutical innovation? |
| title_sort | did medicare induce pharmaceutical innovation |
| topic | Ökonometrisches Modell Aged United States Drug Industry economics United States Medicare Costs Evaluation Medicare economics Older people Medical care Economic aspects Pharmaceutical Preparations economics United States Prescription pricing Econometric models |
| topic_facet | Ökonometrisches Modell Aged United States Drug Industry economics United States Medicare Costs Evaluation Medicare economics Older people Medical care Economic aspects Pharmaceutical Preparations economics United States Prescription pricing Econometric models USA |
| url | http://papers.nber.org/papers/w11949.pdf |
| volume_link | (DE-604)BV002801238 |
| work_keys_str_mv | AT acemogludaron didmedicareinducepharmaceuticalinnovation AT cutlerdavidm didmedicareinducepharmaceuticalinnovation AT finkelsteinamy didmedicareinducepharmaceuticalinnovation AT linnjoshua didmedicareinducepharmaceuticalinnovation |